Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Simulation based learning as a strategy for patient education training in medical students.

Scientific reports·2026
Same author

Global prevalence of CFTR variants with respect to their responsiveness to elexacaftor-tezacaftor-ivacaftor.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2025
Same author

Addressing pain in people living with cystic fibrosis: Cystic fibrosis foundation evidence-informed guidelines.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2024
Same author

Development and validation of a clinical score for early diagnosis of constipation in critically ill children.

Scientific reports·2023
Same author

Gastric residual volume management in pediatric intensive care units in Spain and Latin America.

Medicina intensiva·2022
Same author

Hyperchloremia and hypernatremia in critically ill children.

Medicina intensiva·2021

Related Experiment Video

Updated: May 25, 2026

Normothermic Negative Pressure Ventilation Ex Situ Lung Perfusion: Evaluation of Lung Function and Metabolism
09:31

Normothermic Negative Pressure Ventilation Ex Situ Lung Perfusion: Evaluation of Lung Function and Metabolism

Published on: February 14, 2022

[Continuous propofol perfusion in critically ill children].

S C Agudelo1, S Mencía, A Faro

  • 1Servicio de Cuidado Intensivo Pediátrico Cardiovascular, Fundación Cardioinfantil, Facultad Pontifícia de Medicina, Universidad Javeriana, Bogotá, Colombia.

Medicina Intensiva
|January 17, 2012
PubMed
Summary

Continuous propofol infusion (2.1 mg/kg/h) provided safe sedation for critically ill children, with no serious adverse events observed. Further research is recommended to fully understand its effects and safety profile in pediatric intensive care.

More Related Videos

An Open-Source Normothermic Perfusion System Designed for Research Scientists
11:23

An Open-Source Normothermic Perfusion System Designed for Research Scientists

Published on: July 18, 2025

Guidelines for Elective Pediatric Fiberoptic Intubation
11:19

Guidelines for Elective Pediatric Fiberoptic Intubation

Published on: January 17, 2011

Related Experiment Videos

Last Updated: May 25, 2026

Normothermic Negative Pressure Ventilation Ex Situ Lung Perfusion: Evaluation of Lung Function and Metabolism
09:31

Normothermic Negative Pressure Ventilation Ex Situ Lung Perfusion: Evaluation of Lung Function and Metabolism

Published on: February 14, 2022

An Open-Source Normothermic Perfusion System Designed for Research Scientists
11:23

An Open-Source Normothermic Perfusion System Designed for Research Scientists

Published on: July 18, 2025

Guidelines for Elective Pediatric Fiberoptic Intubation
11:19

Guidelines for Elective Pediatric Fiberoptic Intubation

Published on: January 17, 2011

Area of Science:

  • Pediatric Critical Care Medicine
  • Pharmacology
  • Anesthesiology

Background:

  • Sedation is crucial for managing critically ill children.
  • Propofol is a widely used anesthetic agent.
  • Data on continuous propofol infusion in pediatric intensive care is limited.

Purpose of the Study:

  • To describe the use of continuous propofol infusion for sedation in critically ill children.
  • To evaluate the safety and efficacy of this sedation method.

Main Methods:

  • Retrospective, descriptive observational study.
  • Involved pediatric patients in a pediatric intensive care unit.
  • Analyzed demographic, clinical, and laboratory data, including adverse effects.

Main Results:

  • 32% of patients received continuous propofol infusion (average dose 2.1 mg/kg/h) for an average of 6.7 days.
  • No cases of propofol infusion syndrome or serious drug-related adverse effects were reported.
  • While some laboratory abnormalities were noted, they were not linked to propofol, and no significant differences in lactate or infection rates were found.

Conclusions:

  • Continuous propofol infusion (1-4 mg/kg/h) appears to be a safe option for sustained sedation in critically ill children.
  • Further studies are necessary to comprehensively assess propofol's effects and safety profile in this population.